Henry A. Fernandez

Henry A. Fernandez is a declared insider at 2 companies (chief executive); the most frequent names are Royalty Pharma plc and MSCI Inc. In total, 44 filings cover trades dated from 31 December 2015 to 28 April 2026.

No open-market sale appears; the market trades are 7 purchases worth €9.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 32 share grants. In 2026 alone, the filings show 1 purchase and no sales.

The median purchase comes to €348k. Of 7 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 30 April 2026, the filings show a transaction in MSCI Inc. The most recent open-market purchase was published on 17 February 2026, 243 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.